APA

Shiba N., Ohki K., Kobayashi T., Hara Y., Yamato G., Tanoshima R., Ichikawa H., Tomizawa D., Park M., Shimada A., Sotomatsu M., Arakawa H., Horibe K., Adachi S., Taga T., Tawa A. & Hayashi Y. (20160621). High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial. : British journal of haematology.

Chicago

Shiba Norio, Ohki Kentaro, Kobayashi Tohru, Hara Yusuke, Yamato Genki, Tanoshima Reo, Ichikawa Hitoshi, Tomizawa Daisuke, Park Myoung-Ja, Shimada Akira, Sotomatsu Manabu, Arakawa Hirokazu, Horibe Keizo, Adachi Souichi, Taga Takashi, Tawa Akio and Hayashi Yasuhide. 20160621. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial. : British journal of haematology.

Harvard

Shiba N., Ohki K., Kobayashi T., Hara Y., Yamato G., Tanoshima R., Ichikawa H., Tomizawa D., Park M., Shimada A., Sotomatsu M., Arakawa H., Horibe K., Adachi S., Taga T., Tawa A. and Hayashi Y. (20160621). High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial. : British journal of haematology.

MLA

Shiba Norio, Ohki Kentaro, Kobayashi Tohru, Hara Yusuke, Yamato Genki, Tanoshima Reo, Ichikawa Hitoshi, Tomizawa Daisuke, Park Myoung-Ja, Shimada Akira, Sotomatsu Manabu, Arakawa Hirokazu, Horibe Keizo, Adachi Souichi, Taga Takashi, Tawa Akio and Hayashi Yasuhide. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial. : British journal of haematology. 20160621.